Background: Although considering the pathophysiology of post-coarctectomy hypertension, β-blockers should be effective, experience with labetalol for treatment is limited in the literature.

Methods: Retrospective collection and analysis of data in children aged ≤6 years following coarctectomy in our tertiary care university medical center between January 2009 and June 2018.

Results: 96 patients were included, 45 were treated with intravenous labetalol and 51 received no treatment. Median time to maximum dose received (median 1.1 mg/kg/h) was 2.7 h, and median time to the reduction of labetalol dose was 8.3 h. No antihypertensives had to be added. In one child, labetalol was switched to nitroprusside due to bronchoconstriction. Of patients receiving intravenous labetalol, 48% had been switched to oral labetalol at discharge.

Conclusions: Intravenous labetalol is a fast, effective, and safe drug to treat hypertension following aortic coarctation repair. Labetalol is easily converted to oral therapy when the continuation of treatment is considered necessary.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9615340PMC
http://dx.doi.org/10.1177/21501351221111797DOI Listing

Publication Analysis

Top Keywords

intravenous labetalol
12
post-coarctectomy hypertension
8
labetalol
8
median time
8
treatment
4
treatment post-coarctectomy
4
hypertension labetalol-a
4
labetalol-a 9-year
4
9-year single-center
4
single-center experience
4

Similar Publications

A 45-year-old female with poorly controlled HTN presented with sudden, painless bilateral vision loss over 12 hours. On examination, she had only light perception in both eyes, with normal fundoscopy and no focal neurological deficits. Laboratory tests revealed mildly elevated creatinine and proteinuria.

View Article and Find Full Text PDF

A highly sensitive and rapid LC-MS/MS method was developed and validated for the quantification of dexamethasone in rat plasma and brain tissue. Protein precipitation method was used for sample preparation. The separation of dexamethasone and the IS (labetalol) was achieved on an Atlantis dC column using an isocratic mobile phase (10 mM ammonium formate and acetonitrile, 25/75, v/v) delivered at 0.

View Article and Find Full Text PDF

Hypertension is the most common pregnancy disorder and can lead to life-threatening conditions for both mother and fetus. However, managing this condition with oral and intravenous labetalol can be challenging, highlighting the need for alternative delivery methods. This study presents, for the first time, the development of novel powder-based reservoirs incorporated with hydrogel-forming microarray patches (MAPs) to facilitate the transdermal delivery of labetalol hydrochloride (HCl).

View Article and Find Full Text PDF

Rheumatoid Arthritis: A Rare Cause of Pachymeningitis and Optic Neuritis.

Eur J Case Rep Intern Med

November 2024

Department of Internal Medicine, Tower Health, Reading Hospital, West Reading, USA.

Introduction: Rheumatoid pachymeningitis and optic neuritis are rare complications of rheumatoid arthritis (RA) and are a diagnosis of exclusion.

Case Description: A 75-year-old male with a history of seronegative RA presented to the emergency department with left eye pain and blurry vision lasting two days. He had been diagnosed with seronegative RA around nine months previously.

View Article and Find Full Text PDF
Article Synopsis
  • Acute hypertension is common in postcraniotomy patients, prompting many to require antihypertensive treatment due to the risk of intracranial hemorrhage.
  • A national survey conducted among neurosurgical residents revealed that most programs set specific systolic blood pressure (SBP) goals post-surgery, primarily aiming for SBP below 140 mm Hg or 160 mm Hg.
  • The most frequently used medications to manage blood pressure were intravenous nicardipine and labetalol, with practices generally consistent until the next morning after surgery.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!